PCM
AVNS

Piermont Capital Management’s Avanos Medical AVNS Stock Holding History

Piermont Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50,770
Closed -$2.34M – 238
2018
Q1 		$2.34M Buy
50,770
+1,130
+2% +$53.6K 0.78% 40
2017
Q4 		$2.29M Sell
49,640
-1,870
-4% -$85.9K 0.75% 51
2017
Q3 		$2.32M Hold
51,510
– – 0.77% 49
2017
Q2 		$2.02M Sell
51,510
-13,160
-20% -$497K 0.58% 60
2017
Q1 		$2.46M Buy
+64,670
New +$2.52M 0.59% 72

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Piermont Capital Management's AVNS Position: Q2 2018 in Review

Piermont Capital Management sold out of Avanos Medical (AVNS) in Q2 2018, closing a stake of 50,770 shares — an estimated $2.34M sold.

Piermont Capital Management first reported a position in AVNS in Q1 2017 and held it in 5 quarters. The position peaked at $2.46M in Q1 2017. 321 funds tracked by Wall St. Rank hold AVNS as of Q2 2018.

  • Piermont Capital Management reported no remaining Avanos Medical position as of Q2 2018 after selling out during the quarter.
  • Piermont Capital Management sold 50,770 Avanos Medical shares in Q2 2018, an estimated $2.34M.
  • Piermont Capital Management first reported a position in Avanos Medical in Q1 2017 and held it in 5 quarters.
  • Piermont Capital Management's Avanos Medical position peaked at $2.46M in Q1 2017.
  • 321 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2018.

Based on Piermont Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.